Get the Stockscreener App
91.47
0.12%
-0.11
After Hours:
91.47
Lantheus Holdings Inc stock is traded at $91.47, with a volume of 572.47K.
It is down -0.12% in the last 24 hours and down -1.28% over the past month.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
See More
Previous Close:
$91.58
Open:
$91.53
24h Volume:
572.47K
Relative Volume:
0.57
Market Cap:
$6.36B
Revenue:
$1.50B
Net Income/Loss:
$427.61M
P/E Ratio:
15.22
EPS:
6.01
Net Cash Flow:
$423.98M
1W Performance:
-4.60%
1M Performance:
-1.28%
6M Performance:
-24.78%
1Y Performance:
+65.50%
1-Day Range:
$90.50
$92.80
1-Week Range:
$87.77
$95.81
52-Week Range:
$50.20
$126.89
Lantheus Holdings Inc Stock (LNTH) Company Profile
Name
Lantheus Holdings Inc
Sector
Phone
978 671-8001
Address
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Compare LNTH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
91.47 | 6.36B | 1.50B | 427.61M | 423.98M | 6.01 |
|
ZTS
Zoetis Inc
|
165.89 | 74.84B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.24 | 41.78B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
12.92 | 40.96B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.92 | 24.83B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
143.26 | 14.50B | 2.24B | 385.90M | 440.10M | 3.73 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-24 | Initiated | Goldman | Buy |
| Sep-03-24 | Initiated | Redburn Atlantic | Buy |
| Jul-10-24 | Reiterated | JMP Securities | Mkt Outperform |
| Dec-18-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-04-23 | Initiated | TD Cowen | Outperform |
| Sep-29-23 | Initiated | William Blair | Outperform |
| Mar-08-23 | Initiated | JMP Securities | Mkt Outperform |
| Nov-30-22 | Initiated | SVB Leerink | Outperform |
| Oct-13-22 | Initiated | Mizuho | Buy |
| May-09-22 | Initiated | B. Riley Securities | Buy |
| Apr-13-22 | Initiated | Truist | Buy |
| Feb-01-21 | Initiated | SVB Leerink | Outperform |
| Jun-29-20 | Resumed | Jefferies | Buy |
| Aug-16-19 | Upgrade | CJS Securities | Market Perform → Market Outperform |
| Nov-02-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Nov-08-16 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-23-16 | Resumed | Credit Suisse | Neutral |
| Feb-24-16 | Reiterated | RBC Capital Mkts | Outperform |
| Dec-11-15 | Downgrade | Credit Suisse | Outperform → Neutral |
| Sep-30-15 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jul-20-15 | Initiated | Credit Suisse | Outperform |
| Jul-20-15 | Initiated | Jefferies | Buy |
| Jul-20-15 | Initiated | RBC Capital Mkts | Outperform |
| Jul-20-15 | Initiated | Robert W. Baird | Outperform |
| Jul-20-15 | Initiated | Wells Fargo | Outperform |
View All
Lantheus Holdings Inc Stock (LNTH) Latest News
Lantheus director James Thrall sells $94,760 in stock - MSN
Shelton Wealth Management LLC Boosts Stock Position in Lantheus Holdings, Inc. (NASDAQ:LNTH) - MarketBeat
3,609 Shares in Lantheus Holdings, Inc. (NASDAQ:LNTH) Acquired by Empirical Asset Management LLC - MarketBeat
Insider Selling: Lantheus Holdings, Inc. (NASDAQ:LNTH) Director Sells 1,000 Shares of Stock - MarketBeat
Lantheus Holdings, Inc. (NASDAQ:LNTH) Shares Sold by Burney Co. - MarketBeat
Lantheus director James Thrall sells $94,760 in stock By Investing.com - Investing.com Canada
Insider Sell: James Thrall Sells 1,000 Shares of Lantheus Holdin - GuruFocus.com
Lantheus Holdings, Inc. – Consensus ‘strong_buy’ rating and 44.2% Upside Potential - DirectorsTalk Interviews
Lantheus Holdings Inc (LNTH) Trading Down 3.47% on Jan 16 - GuruFocus.com
How To Trade (LNTH) - Stock Traders Daily
LNTH: LMI Acquisition and NeuraCeq - MSN
Lantheus Holdings' SWOT analysis: radiopharmaceutical leader's stock faces growth hurdles - Investing.com Canada
Lantheus Holdings’ SWOT analysis: radiopharmaceutical leader’s stock faces growth hurdles - Investing.com Nigeria
What 4 Analyst Ratings Have To Say About Lantheus Holdings - Benzinga
Lantheus Holdings, Inc. (LNTH): A Bull Case Theory - Insider Monkey
Lantheus (NASDAQ:LNTH) Receives "Market Outperform" Rating from JMP Securities - MarketBeat
Lantheus to acquire Life Molecular Imaging for up to $750 million, expanding Alzheimer's PET portfolio - DOTmed HealthCare Business News
Lantheus Holdings, Inc. (NASDAQ:LNTH) Receives $131.86 Consensus Price Target from Brokerages - MarketBeat
Lantheus (LNTH) Acquires Life Molecular Imaging for $750MM&A - HIT Consultant
5 Firms Steer Up-To-$750M Sale Of Life Molecular Imaging - Law360
Lantheus Holdings, Inc. (NASDAQ:LNTH) Holdings Boosted by Reinhart Partners LLC. - MarketBeat
Why Lantheus Holdings (LNTH) Stock Is Down 4% - Benzinga
Lantheus to acquire Life Molecular Imaging - The Pharma Letter
Lantheus Acquires Life Molecular Imaging for $350 Million - TipRanks
American giant buying South African-owned company for R14 billion - BusinessTech
Lantheus to acquire PET agent developer Life Molecular Imaging for up to $750M - Radiology Business
Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million - citybiz
Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer's Disease Radiodiagnostic Market - The Manila Times
Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer’s Disease Radiodiagnostic Market - GlobeNewswire Inc.
Health Check: Radiopharm dials up after gaining new major shareholder - MSN
Harbor Capital Advisors Inc. Has $13.01 Million Stake in Lantheus Holdings, Inc. (NASDAQ:LNTH) - MarketBeat
Radiopharm gets a new, major shareholder - The Cairns Post
Lantheus Increases to 12.16% shareholding in Radiopharm with US$5m (A$8m) Placement - GlobeNewswire
Radiopharm Secures $5M Investment from Lantheus at Stunning 150% Premium for Cancer Drug Development - StockTitan
Radiopharm Theranostics (ASX:RAD, NASDAQ:RADX) Announces US$5Mn Private Placement with Lantheus Holdings - Kalkine Media
Radiopharm Strengthens Ties with Lantheus Through $5 Million Investment - TipRanks
Lantheus Stock Doubled In A Year Amid Wide Use Of Its AI-Enabled Medical Devices - MSN
Lantheus Holdings (NASDAQ:LNTH) jumps 8.3% this week, though earnings growth is still tracking behind five-year shareholder returns - Simply Wall St
Here’s What Lifted Lantheus Holdings (LNTH) in Q3 - Yahoo Finance
Trend Tracker for (LNTH) - Stock Traders Daily
JPMorgan Chase & Co. Has $62.85 Million Stock Holdings in Lantheus Holdings, Inc. (NASDAQ:LNTH) - MarketBeat
Lantheus Holdings, Inc. – Consensus ‘strong_buy’ rating and 50.6% Upside Potential - DirectorsTalk Interviews
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Benzinga
Inplay Oil Corp (IPO-T) QuotePress Release - The Globe and Mail
Lantheus Holdings: Powerhouse Potential In 2025 - Seeking Alpha
LNTH Makes Notable Cross Below Critical Moving Average - Nasdaq
Radiopharm Theranostics Limited Announces Strategic Co-Development Partnership with Lantheus for Australia - Marketscreener.com
Radiopharm Partners with Lantheus to Advance Oncology Treatments - MSN
(LNTH) Technical Data - Stock Traders Daily
Principal Financial Group Inc. Has $26.19 Million Position in Lantheus Holdings, Inc. (NASDAQ:LNTH) - MarketBeat
Options Exercise: BRIAN MARKISON At Lantheus Holdings Realizes $2.73M - Benzinga
Lantheus Holdings Inc Stock (LNTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.08%
0.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):